Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

Clinical trial NCT02281136 · COMPLETED

Trial details

NCT number: NCT02281136
Sponsor: DUSA Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Keratosis, Actinic

Start date: 2014-12-01
Primary completion: 2015-04-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.